Literature DB >> 27080573

No Value for Routine Serologic Screening for Borrelia burgdorferi in Patients With Uveitis in the Netherlands.

Hawkar Kazi1, Jolanda D F de Groot-Mijnes2, Ninette H Ten Dam-van Loon1, Jeannette Ossewaarde-van Norel1, Jan Jelrik Oosterheert3, Joke H de Boer1.   

Abstract

PURPOSE: To determine whether routine serologic screening for Borrelia burgdorferi and subsequent aqueous or vitreous humor analysis is useful in patients with uveitis.
DESIGN: Cross-sectional study.
METHODS: All patients referred to our tertiary uveitis referral clinic in the period of from January 1, 2004 to October 31, 2014, in whom routine serologic screening for Borrelia burgdorferi (IgG as determined by enzyme-linked immunosorbent assay and confirmed by immunoblot) was performed were retrospectively reviewed. In patients with an unclassified uveitis, aqueous and vitreous humor and cerebrospinal fluid were also analyzed. Local antibody production was determined by Goldmann-Witmer coefficient calculation or polymerase chain reaction for B burgdorferi. The seroprevalence of B burgdorferi among patients with uveitis was compared to the general population.
RESULTS: Borrelia burgdorferi screening was performed in 1126 uveitis patients (44.3% male, mean age 45.9 ± 19.6 years). The seroprevalence of B burgdorferi among uveitis patients was 3.7% (95% confidence interval 2.6%-4.8%) (n = 42) as compared to 5%-10% in the general Dutch population. Of these 42 patients, 14 (1.2% of all uveitis patients) had an unclassified uveitis, 7 of whom underwent aqueous humor (n = 5) or vitreous humor (n = 2) analysis and cerebrospinal fluid analysis (n = 2). None of the patients had local antibody production in either ocular or cerebrospinal fluid.
CONCLUSION: The prevalence of immunoblot-confirmed B burgdorferi IgG seropositivity in our uveitis patients is only slightly lower as compared to the general Dutch population. Intraocular antibody production and DNA was absent in all tested patients. These findings do not support routine serologic examination for Borrelia in uveitis patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27080573     DOI: 10.1016/j.ajo.2016.04.002

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Global seroprevalence and sociodemographic characteristics of Borrelia burgdorferi sensu lato in human populations: a systematic review and meta-analysis.

Authors:  Yan Dong; Guozhong Zhou; Wenjing Cao; Xin Xu; Yu Zhang; Zhenhua Ji; Jiaru Yang; Jingjing Chen; Meixiao Liu; Yuxin Fan; Jing Kong; Shiyuan Wen; Bingxue Li; Peng Yue; Aihua Liu; Fukai Bao
Journal:  BMJ Glob Health       Date:  2022-06

2.  Classification Criteria for Intermediate Uveitis, Non-Pars Planitis Type.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-09       Impact factor: 5.488

3.  Classification Criteria For Pars Planitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-15       Impact factor: 5.488

4.  Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-05-11       Impact factor: 5.488

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.